K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 320.20K | 996.10K | -333.80K | 151.80K | -4.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -659.30K | -1.34M | -42.40K | -382.50K | -325.20K |
| Change in Net Operating Assets | -1.11M | -1.10M | -1.26M | 636.30K | -1.64M |
| Cash from Operations | -1.45M | -1.44M | -1.63M | 405.60K | -1.97M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -3.30K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 600.00 | 122.90K | 6.00K | 1.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.74M | 1.27M | 553.00K | 429.40K | 603.10K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 36.40K | -36.40K |
| Cash from Financing | 1.74M | 1.27M | 675.90K | 468.50K | 2.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 292.10K | -165.40K | -956.40K | 874.10K | 166.40K |
